Clinical trials
Completed Observational Scleroderma, Systemic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2005 | 2 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Lille | 6 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Duke University | 2 |
| Meir Medical Center | 2 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2 |
| University Hospital, Bordeaux | 2 |
| University Hospital, Brest | 2 |
| University Hospital, Rouen | 2 |
| University of Manchester | 2 |
| University of Michigan | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Systemic | 57 |
| Scleroderma, Diffuse | 11 |
| Lupus Erythematosus, Systemic | 6 |
| Arthritis, Rheumatoid | 4 |
| Autoimmune Diseases | 4 |
| Hypertension, Pulmonary | 4 |
| Multiple Sclerosis | 4 |
| Scleroderma, Localized | 4 |
| Colitis, Ulcerative | 3 |
| Dermatomyositis | 3 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.